VJOncology is committed to improving our service to you

ESMO 2019 | OpACIN and OpACIN-neo trial updates

VJOncology is committed to improving our service to you

Christian Blank

Christian Blank, MD, PhD, Netherlands Cancer Institute, Amsterdam, The Netherlands, provides an update on the OpACIN (NCT02437279) and OpACIN-neo (NCT02977052) trials, with 3 year and 1.5 year updates respectively. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter